LNPsolution
LNPsolution speeds early-stage drug discovery by using AI and molecular modeling to identify and prioritize hit compounds. The company operates as an in-silico Contract Research Organization (CRO) and SaaS provider that combines AI, deep learning, molecular dynamics and virtual screening to run molecular modeling simulations and reverse screening. It uses industry tools and proprietary workflows including Schrödinger, Maestro, BioLuminate, and LiveDesign alongside bespoke AI models to support virtual screening, biologics modeling, and in-silico services. LNPsolution serves drug discovery companies, research institutions, universities, corporations, and government partners. Its offering targets early discovery workflows to reduce screening time and cost for preclinical research.
LNPsolution
LNPsolution speeds early-stage drug discovery by using AI and molecular modeling to identify and prioritize hit compounds. The company operates as an in-silico Contract Research Organization (CRO) and SaaS provider that combines AI, deep learning, molecular dynamics and virtual screening to run molecular modeling simulations and reverse screening. It uses industry tools and proprietary workflows including Schrödinger, Maestro, BioLuminate, and LiveDesign alongside bespoke AI models to support virtual screening, biologics modeling, and in-silico services. LNPsolution serves drug discovery companies, research institutions, universities, corporations, and government partners. Its offering targets early discovery workflows to reduce screening time and cost for preclinical research.